HK1098684A1 - Alkaloid formulations - Google Patents

Alkaloid formulations

Info

Publication number
HK1098684A1
HK1098684A1 HK07105129.6A HK07105129A HK1098684A1 HK 1098684 A1 HK1098684 A1 HK 1098684A1 HK 07105129 A HK07105129 A HK 07105129A HK 1098684 A1 HK1098684 A1 HK 1098684A1
Authority
HK
Hong Kong
Prior art keywords
alkaloid
alkaloid formulations
formulations
alkaloids
reaction product
Prior art date
Application number
HK07105129.6A
Other languages
English (en)
Inventor
Simon Michael West
Esra Ogru
Robert Gianello
Original Assignee
Vital Health Sciences Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2004901107A external-priority patent/AU2004901107A0/en
Application filed by Vital Health Sciences Pty Ltd filed Critical Vital Health Sciences Pty Ltd
Publication of HK1098684A1 publication Critical patent/HK1098684A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
HK07105129.6A 2004-03-03 2007-05-15 Alkaloid formulations HK1098684A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2004901107A AU2004901107A0 (en) 2004-03-03 Alkaloid formulation
AU2004904367A AU2004904367A0 (en) 2004-08-03 Alkaloid formulations
PCT/AU2005/000307 WO2005084678A1 (fr) 2004-03-03 2005-03-03 Formulations alcaloides

Publications (1)

Publication Number Publication Date
HK1098684A1 true HK1098684A1 (en) 2007-07-27

Family

ID=34921028

Family Applications (1)

Application Number Title Priority Date Filing Date
HK07105129.6A HK1098684A1 (en) 2004-03-03 2007-05-15 Alkaloid formulations

Country Status (15)

Country Link
US (2) US20060281716A1 (fr)
EP (1) EP1720551B9 (fr)
JP (1) JP4847437B2 (fr)
KR (1) KR101173159B1 (fr)
AT (1) ATE495730T1 (fr)
AU (1) AU2005202477B2 (fr)
BR (1) BRPI0508125A (fr)
CA (1) CA2557354C (fr)
DE (1) DE602005025979D1 (fr)
DK (1) DK1720551T3 (fr)
HK (1) HK1098684A1 (fr)
IL (1) IL177781A (fr)
NZ (1) NZ549567A (fr)
RU (1) RU2477136C2 (fr)
WO (1) WO2005084678A1 (fr)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1262274C (zh) * 2000-11-14 2006-07-05 生命健康科学有限公司 磷酸盐衍生物复合物
AUPR549901A0 (en) * 2001-06-06 2001-07-12 Vital Health Sciences Pty Ltd Topical formulation containing tocopheryl phosphates
CA2453823C (fr) * 2001-07-27 2010-12-21 Vital Health Sciences Pty Ltd Therapie dermique mettant en oeuvre des derives de phosphate d'agents de transfert electroniques
CN1604772A (zh) * 2001-12-13 2005-04-06 生命健康科学有限公司 化合物的透皮转运
AU2002950713A0 (en) 2002-08-09 2002-09-12 Vital Health Sciences Pty Ltd Carrier
CA2513427C (fr) * 2003-01-17 2012-03-27 Vital Health Sciences Pty Ltd. Composes possedant des proprietes antiproliferatives
AU2003901815A0 (en) * 2003-04-15 2003-05-01 Vital Health Sciences Pty Ltd Phosphate derivatives
JP4847437B2 (ja) 2004-03-03 2011-12-28 バイタル ヘルス サイエンシズ プロプライアタリー リミティド アルカロイド製剤
JP5198858B2 (ja) * 2004-08-03 2013-05-15 バイタル ヘルス サイエンシズ プロプライアタリー リミティド 腸内投与のための担体
KR20070108382A (ko) * 2005-03-03 2007-11-09 바이탈 헬스 사이언시즈 피티와이 리미티드 항암성 화합물
US20090239827A1 (en) * 2005-03-03 2009-09-24 Esra Ogru Compounds having lipid lowering properties
MX2007015949A (es) * 2005-06-17 2008-03-07 Vital Health Sciences Pty Ltd Un vehiculo que comprende uno o mas derivados de fosfato de di- y/o mono-(agentes de transferencia de electrones) o complejos de los mismos.
EP1973547A1 (fr) * 2005-12-23 2008-10-01 Vital Health Sciences Pty Ltd. Composés ayant des propriétés modulatrices de la cytokine
AU2011213557B2 (en) 2010-02-05 2015-05-07 Phosphagenics Limited Carrier comprising non-neutralised tocopheryl phosphate
CA2794734C (fr) * 2010-03-30 2017-12-12 Phosphagenics Limited Timbre transdermique
EP2685992A4 (fr) 2011-03-15 2014-09-10 Phosphagenics Ltd Amino-quinoléines en tant qu'inhibiteurs de kinase
US10402738B2 (en) 2012-12-03 2019-09-03 National Ict Australia Limited Bayesian nonparametric method for infrastructure failure prediction
TWI685497B (zh) * 2014-06-02 2020-02-21 西班牙商伊史帝夫製藥公司 具有多重模式抗疼痛活性的１-氧雜-４,９-二氮雜螺十一烷化合物之烷基衍生物
BR112018009279A8 (pt) 2015-11-16 2019-02-26 Esteve Pharmaceuticals Sa compostos de oxadiazaespiro para o tratamento de abuso de droga e adicção
RU2742650C2 (ru) * 2015-12-09 2021-02-09 Фосфейдженикс Лимитед Фармацевтический состав
CA3007587C (fr) * 2015-12-09 2023-12-05 Phosphagenics Limited Formulation pharmaceutique
BR112019012946A2 (pt) 2016-12-21 2019-11-26 Avecho Biotechnology Ltd processo

Family Cites Families (182)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2407823A (en) * 1946-09-17 Antihemorrhagic esters and methods
US2667479A (en) * 1951-01-30 1954-01-26 Merck & Co Inc Benzimidazole phosphate
GB778142A (en) 1953-11-20 1957-07-03 Leo Ab High-molecular weight derivatives of hydroxyl group-containing steroids and a method of producing them
US2913477A (en) * 1957-03-22 1959-11-17 Merck & Co Inc Antihemorrhagic compounds and processes for preparing the same
US3127434A (en) * 1959-10-20 1964-03-31 Hoffmann La Roche Dihydrovitamin k monophosphate compounds and preparation thereof
US3212901A (en) * 1961-06-07 1965-10-19 Eastman Kodak Co Stabilized tocopherol concentrates and process for preparing the same
US3331896A (en) 1964-09-15 1967-07-18 Gen Aniline & Film Corp Method of preparing alkali soluble phosphate esters of hydroxylic organic compounds
US3607765A (en) 1968-11-29 1971-09-21 Colgate Polmolive Co Detergent softener compositions
DE2526938C2 (de) * 1975-02-14 1982-04-22 F. Hoffmann-La Roche & Co. AG, 4002 Basel Vitaminpräparate
US4141938A (en) * 1976-10-07 1979-02-27 Hoechst Aktiengesellschaft Production of acid orthophosphoric acid ester mixtures
US4444755A (en) * 1978-01-23 1984-04-24 Efamol Limited Treatment for skin disorders
US4299906A (en) * 1979-06-01 1981-11-10 American Hoechst Corporation Light-sensitive color proofing film with surfactant in a light-sensitive coating
SU925961A1 (ru) 1980-08-15 1982-05-07 Московский ордена Трудового Красного Знамени технологический институт пищевой промышленности Способ получени фосфорилированных глицеридов высших жирных кислот
US4369172A (en) * 1981-12-18 1983-01-18 Forest Laboratories Inc. Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose
IT1157269B (it) * 1982-03-19 1987-02-11 Seuref Ag Nuove formulazioni farmaceutiche contenenti il coenzima q10 adatte per la somministrazione topica
CH661438A5 (it) * 1984-04-09 1987-07-31 Seuref Ag Composizioni farmaceutiche ad azione antianossica e metabolica cerebrale.
US4977282A (en) 1984-04-17 1990-12-11 Henkel Corporation Production of d-alpha-tocopherol from natural plant sources
US4603142A (en) 1984-06-01 1986-07-29 Wisconsin Alumni Research Foundation Cholesterol lowering method of use
DE3582904D1 (de) 1984-08-02 1991-06-27 Henkel Corp Reinigung von tocopherolen durch extraktion.
JPS6191137A (ja) * 1984-10-11 1986-05-09 Kao Corp 外用薬剤組成物
JPH0781138B2 (ja) 1986-12-02 1995-08-30 株式会社資生堂 抗酸化剤
DE3702766A1 (de) * 1987-01-30 1988-08-11 Henkel Kgaa Verfahren zur herstellung und isolierung von monoalkylphosphorsaeureestern
JP3070744B2 (ja) * 1987-04-10 2000-07-31 株式会社日立製作所 ベクトル処理装置
US4952495A (en) * 1987-06-08 1990-08-28 Eastman Kodak Company Hydrolyzable compounds which release electron transfer agents and analytical use of same
PH25859A (en) 1988-01-11 1991-12-02 Takeda Chemical Industries Ltd Composition for treatment of ischemic disorder
US5446070A (en) * 1991-02-27 1995-08-29 Nover Pharmaceuticals, Inc. Compositions and methods for topical administration of pharmaceutically active agents
DE3813624A1 (de) 1988-04-22 1989-11-02 Basf Ag Verfahren zur herstellung von d-(alpha)-tocopherol aus natuerlichen vorprodukten
CA2007643A1 (fr) 1989-02-01 1990-08-01 Donald S. Karanewsky Combinaison d'un inhibiteur de hmg coa et d'un inhibiteur de squalene synthetase et methode pour abaisser le taux de cholesterol sanguin par l'utilisation de cette combinaison
US6028105A (en) 1989-04-06 2000-02-22 Nigra; Thomas P. Topical drug delivery composition and method
US5053222A (en) * 1989-06-07 1991-10-01 Shiseido Company Ltd. Hair cosmetic composition
US5094848A (en) 1989-06-30 1992-03-10 Neorx Corporation Cleavable diphosphate and amidated diphosphate linkers
DE3927113C2 (de) * 1989-08-17 1993-11-25 Dolorgiet Gmbh & Co Kg Mittel zur Behandlung von schweren Schmerzzuständen und Verfahren zu ihrer Herstellung
JP2854631B2 (ja) 1989-11-21 1999-02-03 千寿製薬株式会社 糖尿病合併症および老化によって引き起こされる疾患の予防・治療剤
IT1236843B (it) * 1989-11-22 1993-04-21 Simes Processo per la preparazione di 4-0-fosfati di dopamina o suoi derivati
JPH03206089A (ja) 1990-01-05 1991-09-09 Eisai Co Ltd 新規ビタミンｅ誘導体及びその製造方法
US5374645A (en) * 1990-01-22 1994-12-20 Ciba-Geigy Corporation Transdermal administation of ionic pharmaceutically active agents via aqueous isopropanol
FR2657526B1 (fr) * 1990-01-31 1994-10-28 Lvmh Rech Utilisation d'un phosphate d'alpha-tocopherol, ou de l'un de ses derives, pour la preparation de compositions cosmetiques, dermatologiques, ou pharmaceutiques; compositions ainsi obtenues.
US5041434A (en) * 1991-08-17 1991-08-20 Virginia Lubkin Drugs for topical application of sex steroids in the treatment of dry eye syndrome, and methods of preparation and application
US5114957A (en) 1990-05-08 1992-05-19 Biodor U.S. Holding Tocopherol-based antiviral agents and method of using same
SE9003665D0 (sv) * 1990-11-16 1990-11-16 Kabivitrum Ab Morphine prodrugs
US5643597A (en) * 1991-08-01 1997-07-01 Lvmh Recherche Use of a tocopherol phosphate or one of its derivatives for the preparation of cosmetic or pharmaceutical compositions and compositions so obtained
FR2679904A1 (fr) * 1991-08-01 1993-02-05 Lvmh Rech Utilisation d'un phosphate de tocopherol, ou de l'un de ses derives, pour la preparation de compositions cosmetiques, ou pharmaceutiques et compositions ainsi obtenues.
EP0535283A1 (fr) 1991-10-02 1993-04-07 Merrell Dow Pharmaceuticals Inc. Analogues de tocophérol cardioprotectives
US5474891A (en) * 1991-10-30 1995-12-12 Thomas Jefferson University Plasma-based platelet concentrate preparations with additive
ATE181667T1 (de) 1991-11-11 1999-07-15 Hisamitsu Pharmaceutical Co Ketorolac enthaltender warmer umschlag
CA2124086A1 (fr) * 1991-11-22 1993-05-27 Ronald H. Lane Tocotrienols, composes apparentes aux tocotrienols et methodes d'utilisation
US5282312A (en) * 1991-12-31 1994-02-01 Tessera, Inc. Multi-layer circuit construction methods with customization features
JP3202775B2 (ja) * 1992-01-29 2001-08-27 エスエス製薬株式会社 固形製剤
JP3207494B2 (ja) 1992-04-02 2001-09-10 ロート製薬株式会社 水性懸濁製剤
JPH05286848A (ja) 1992-04-10 1993-11-02 Senju Pharmaceut Co Ltd 浴用剤
GB9212450D0 (en) 1992-06-11 1992-07-22 Indena Spa New derivatives of non-steroidal anti-inflammatory,analgesic and/or antipyretic substances,their use and pharmaceutical formulations containing them
US5741518A (en) * 1992-08-03 1998-04-21 L'oreal Composition composed of an aqueous dispersion of stabilized vesicles of nonionic amphiphilic lipids
US5773457A (en) * 1995-02-15 1998-06-30 Cesar Roberto Dias Nahoum Compositions
WO1994008599A1 (fr) * 1992-10-14 1994-04-28 The Regents Of The University Of Colorado Appariement d'ions de medicaments pour ameliorer l'efficacite et l'administration
US5348357A (en) 1992-12-24 1994-09-20 General Motors Corporation Vehicle closure latch having plastic coated ratchet
US6384043B1 (en) * 1993-02-01 2002-05-07 Gholam A. Peyman Methods of alleviating pain sensations of the denuded eye with opioid analgesics
TW252918B (fr) 1993-03-31 1995-08-01 Senju Pharma Co
GB9318271D0 (en) 1993-09-03 1993-10-20 Scotia Holdings Plc Tocopherols
CA2129509A1 (fr) 1993-09-10 1995-03-11 Kazumi Ogata Composition pharmaceutique pour les troubles renaux et solution de dialyse pour l'hemodialyse extracorporelle
CA2176743A1 (fr) * 1993-11-27 1995-06-01 Brian Christopher Challis Compositions comprenant des capteurs d'ions iminium et/ou de nitrite
JPH07196516A (ja) 1993-12-29 1995-08-01 Senju Pharmaceut Co Ltd 痔疾患治療剤
FR2714595B1 (fr) 1993-12-30 1996-02-02 Oreal Emulsion eau dans huile contenant du rétinol, son utilisation et son conditionnement.
FR2715565B1 (fr) * 1994-01-31 1996-03-15 Oreal Composition cosmétique ou dermatologique stabilisée contenant plusieurs précurseurs d'un même actif pour maximaliser sa libération, son utilisation.
US5444957A (en) * 1994-02-01 1995-08-29 Roberts; Walter R. Multistory slab construction
EP0669132A1 (fr) 1994-02-23 1995-08-30 van der Kraaij, Antonius Marinus Maria Composition pharmaceutique à la vitamine E et à l'acetylsalicylate pour le traitement et la prévention de l'atherosclerosis
CA2145229A1 (fr) 1994-03-29 1995-09-30 Tetsuya Toge Compositions suppressives de metastases hepatiques
US5554781A (en) * 1994-03-30 1996-09-10 Reierson; Robert L. Monoalkyl phosphonic acid ester production process
JPH07277988A (ja) 1994-04-05 1995-10-24 Senju Pharmaceut Co Ltd 局所用掻痒除去、治療剤
TW287103B (fr) 1994-04-22 1996-10-01 Senju Pharma Co
JP3362501B2 (ja) 1994-04-28 2003-01-07 千寿製薬株式会社 角膜障害治療剤
JP3396953B2 (ja) 1994-05-10 2003-04-14 千寿製薬株式会社 網膜疾患予防・治療剤
US5589504A (en) * 1994-07-26 1996-12-31 Cornell Research Foundation, Inc. Treatment of newborn jaundice
CA2152693A1 (fr) 1994-08-05 1996-02-06 Kazumi Ogata Composition therapeutique pour la pancreatite
IT1274734B (it) 1994-08-25 1997-07-24 Prospa Bv Composizioni farmaceutiche contenenti acidi grassi poliinsaturi, loro esteri o sali, unitamente a vitamine o provitamine antiossidanti
JPH0873338A (ja) * 1994-09-02 1996-03-19 Noevir Co Ltd 皮膚外用剤
HU215966B (hu) * 1994-11-21 1999-07-28 BIOGAL Gyógyszergyár Rt. Orálisan alkalmazható, ciklosporint tartalmazó, összetett emulzió-előkoncentrátum
DE4444238A1 (de) 1994-12-13 1996-06-20 Beiersdorf Ag Kosmetische oder dermatologische Wirkstoffkombinationen aus Zimtsäurederivaten und Flavonglycosiden
FR2730928B1 (fr) * 1995-02-23 1997-04-04 Oreal Composition a base de vesicules lipidiques a ph acide et son utilisation en application topique
CA2193742A1 (fr) 1995-04-21 1996-10-24 Tatsuo Shimizu Preparations a usage externe destinees au traitement de dermatoses
US5607968A (en) * 1995-06-07 1997-03-04 Avon Products, Inc. Topical alkyl-2-O-L-ascorbyl-phosphates
US5965750A (en) * 1995-10-17 1999-10-12 Showa Denko K.K. High- purity tocopherol phosphates, process for the preparation thereof, methods for analysis thereof, and cosmetics
FR2741263B1 (fr) 1995-11-22 1997-12-26 Oreal Composition comprenant une dispersion aqueuse de vesicules lipidiques encapsulant un filtre uv a fonction acide et utilisations en application topique
DE69736468T2 (de) 1996-03-27 2007-03-29 Inspire Pharmaceuticals, Inc. Verfahren zur behandlung der ziliardyskinesie mit uridintriphosphaten und verwandten verbindungen
US6077828A (en) 1996-04-25 2000-06-20 Abbott Laboratories Method for the prevention and treatment of cachexia and anorexia
US5885595A (en) * 1996-05-13 1999-03-23 Elizabeth Arden Co., Division Of Conopco, Inc. Cosmetic composition with a retinol fatty acid ester
CA2209690A1 (fr) * 1996-07-31 1998-01-31 Sachiko Matsuura Medicament pour le traitement de l'acne commune
JPH1067639A (ja) 1996-08-26 1998-03-10 Shiseido Co Ltd ビタミンｅ−ビタミンｃリン酸ジエステル／シクロデキストリン包接物及び該包接物を配合した皮膚外用剤
US6022867A (en) * 1996-11-27 2000-02-08 Showa Denko Kabushiki Kaisha Method of administering vitamin E to animals and compositions containing tocopheryl phosphates and salts thereof for animals
JPH10155429A (ja) 1996-11-27 1998-06-16 Showa Denko Kk 動物に対するビタミンｅ供給方法および動物用トコフェロールリン酸エステル又はその塩類組成物
US6458373B1 (en) 1997-01-07 2002-10-01 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
US6727280B2 (en) 1997-01-07 2004-04-27 Sonus Pharmaceuticals, Inc. Method for treating colorectal carcinoma using a taxane/tocopherol formulation
US5804168A (en) * 1997-01-29 1998-09-08 Murad; Howard Pharmaceutical compositions and methods for protecting and treating sun damaged skin
US6932975B2 (en) 1997-01-29 2005-08-23 Kao Corporation Cosmetic composition comprising a phosphoric triester and a skin activating component
AU731186B2 (en) * 1997-03-13 2001-03-29 Hexal Ag Stabilization of acid sensitive benzimidazols with amino acid/cyclodextrin combinations
US7179486B1 (en) * 1997-04-01 2007-02-20 Nostrum Pharmaceuticals, Inc. Process for preparing sustained release tablets
JP2926046B2 (ja) * 1997-06-04 1999-07-28 株式会社太平洋 水安定型ｌ−アスコルビン酸誘導体とその製造方法及びこれを含有する美白化粧料組成物
US5928631A (en) * 1997-06-09 1999-07-27 The Procter & Gamble Company Methods for controlling environmental odors on the body using compositions comprising uncomplexed cyclodextrins
US5906811A (en) * 1997-06-27 1999-05-25 Thione International, Inc. Intra-oral antioxidant preparations
US5776915A (en) 1997-08-12 1998-07-07 Clarion Pharmaceuticals Inc. Phosphocholines of retinoids
US6096326A (en) * 1997-08-15 2000-08-01 Scandinavian-American Import/Export Corporation Skin care compositions and use
IT1294748B1 (it) 1997-09-17 1999-04-12 Permatec Tech Ag Formulazione per un dispositivo transdermico
EP1051181B1 (fr) 1997-12-31 2004-03-17 The University Of Kansas Remedes contenant des precurseurs hydrosolubles d'amines tertiaires, et leurs procedes d'obtention
CA2319020A1 (fr) 1998-02-03 1999-08-12 Senju Pharmaceutical Co., Ltd. Substances preventives et medicaments destines aux maladies neurodegeneratives
FR2777179A1 (fr) 1998-04-09 1999-10-15 Lvmh Rech Compositions cosmetiques ou dermatologiques comprenant un vehicule a base d'un liquide hydrophobe
US6461623B2 (en) * 1998-04-13 2002-10-08 Kao Corporation Cosmetic composition
JP4208209B2 (ja) 1998-06-22 2009-01-14 フジノン株式会社 コリメータレンズおよびこれを用いた光走査装置
US6121249A (en) * 1998-07-01 2000-09-19 Donald L. Weissman Treatment and prevention of cardiovascular diseases with help of aspirin, antioxidants, niacin, and certain B vitamins
EP1094781B1 (fr) * 1998-07-07 2008-07-02 Transdermal Technologies Inc. Compositions d'administration transdermique rapide et non irritante d'agents pharmaceutiques actifs et methodes pour la formulation de ces compositions et leur administration
US6703384B2 (en) * 1998-09-23 2004-03-09 Research Development Foundation Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof
WO2000016772A1 (fr) * 1998-09-23 2000-03-30 Research Development Foundation Tocopherols, tocotrienols, autres derives de chromane et de chaines laterales et leurs utilisations
US6770672B1 (en) * 1998-09-23 2004-08-03 Research Development Foundation Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof
US6153582A (en) 1998-11-05 2000-11-28 Bausch & Lomb Surgical, Inc. Defined serumfree medical solution for ophthalmology
US6048891A (en) * 1998-12-17 2000-04-11 Loma Linda University Medical Center Use of γ-tocopherol and its oxidative metabolite LLU-α in the treatment of natriuretic disease
AUPQ037499A0 (en) * 1999-05-14 1999-06-10 Swig Pty Ltd Improved process for phosphorylation and compounds produced by this method
AUPP829399A0 (en) * 1999-01-25 1999-02-18 Swig Pty Ltd Recovery for chroman derivatives
JP2000212082A (ja) 1999-01-26 2000-08-02 Showa Denko Kk 皮膚用剤
US6156354A (en) * 1999-01-29 2000-12-05 Brandeis University Hyper-absorption of vitamin E dispersed in milks
US6184247B1 (en) * 1999-05-21 2001-02-06 Amway Corporation Method of increasing cell renewal rate
WO2000072862A1 (fr) * 1999-06-01 2000-12-07 Ocean Spray Cranberries, Inc. Extrait d'huile de graines de canneberge et compositions contenant ses constituants
US6669951B2 (en) 1999-08-24 2003-12-30 Cellgate, Inc. Compositions and methods for enhancing drug delivery across and into epithelial tissues
WO2001015593A2 (fr) * 1999-09-02 2001-03-08 Drake Larson Compositions de reduction de formation de la plaque vasculaire et procedes d'utilisation associes
AU7719100A (en) * 1999-09-27 2001-04-30 Panayiotis Constantinides Compositions of tocol-soluble therapeutics
JP2001169731A (ja) 1999-12-17 2001-06-26 Showa Denko Kk 動物体の脂質代謝改善剤
RU2263672C2 (ru) * 2000-02-11 2005-11-10 Рисерч Дивелопмент Фаундейшн Токоферолы, токотриенолы, другие хроманы и производные по боковым цепям и их применение
US6635253B2 (en) * 2000-02-29 2003-10-21 Showa Denko Kabushiki Kaisha Composition for enhancing immunological effects
US6346544B2 (en) * 2000-03-02 2002-02-12 Oklahoma Medical Research Foundation Desmethyl tocopherols for protecting cardiovascular tissue
JP2001247585A (ja) 2000-03-03 2001-09-11 Nof Corp トコフェロール誘導体、その中間体、その製造方法及び用途
US6444220B2 (en) * 2000-03-16 2002-09-03 Teresa S. Wiley Method and compositions for changing the contour of skin
US6361800B1 (en) * 2000-04-13 2002-03-26 Cooper Concepts, Inc. Multi-vitamin and mineral supplement
US6485950B1 (en) 2000-07-14 2002-11-26 Council Of Scientific And Industrial Research Isozyme of autoclavable superoxide dismutase (SOD), a process for the identification and extraction of the SOD in cosmetic, food and pharmaceutical compositions
KR100365070B1 (ko) 2000-08-29 2002-12-16 주식회사 태평양 토코페롤 유도체 및 그의 제조방법
JP4818500B2 (ja) 2000-09-05 2011-11-16 株式会社ペンタプラストア トコトリエノール誘導体及びその製造方法
US20030206972A1 (en) * 2000-10-13 2003-11-06 Babish John G. Compositions containing carotenoids and tocotrienols and having synergistic antioxidant effect
WO2002040033A1 (fr) * 2000-11-14 2002-05-23 Vital Health Sciences Pty Ltd Formulation contenant des derives de phosphate d'agents de transfert d'electrons
CN1262274C (zh) * 2000-11-14 2006-07-05 生命健康科学有限公司 磷酸盐衍生物复合物
AUPR549901A0 (en) * 2001-06-06 2001-07-12 Vital Health Sciences Pty Ltd Topical formulation containing tocopheryl phosphates
US20020132845A1 (en) 2000-12-15 2002-09-19 Miller Guy Michael Compositions and methods for the prevention and treatment of tissue ischemia
US20020151467A1 (en) * 2000-12-21 2002-10-17 Leung Frank K. Methods and compositions for oral insulin delivery
US20020131994A1 (en) * 2001-01-10 2002-09-19 Schur Henry B. Non-irritating formulation for the transdermal delivery of substances
US6849271B2 (en) * 2001-04-27 2005-02-01 Verion, Inc. Microcapsule matrix microspheres, absorption-enhancing pharmaceutical compositions and methods
TW576859B (en) 2001-05-11 2004-02-21 Shipley Co Llc Antireflective coating compositions
KR100394770B1 (ko) 2001-06-05 2003-08-14 주식회사 태평양 토코페롤 유도체를 이용하여 나노유화입자를 안정화시키는방법 및 나노유화입자를 함유하는 피부 외용제 조성물
CA2453823C (fr) * 2001-07-27 2010-12-21 Vital Health Sciences Pty Ltd Therapie dermique mettant en oeuvre des derives de phosphate d'agents de transfert electroniques
AUPR684801A0 (en) * 2001-08-06 2001-08-30 Vital Health Sciences Pty Ltd Supplement therapy
US20040253310A1 (en) * 2001-09-21 2004-12-16 Gina Fischer Morphine polymer release system
EP2957281A1 (fr) * 2001-09-21 2015-12-23 Egalet Ltd. Systeme de liberation a base de polymere
AU2002951045A0 (en) * 2002-08-27 2002-09-12 Vital Health Sciences Pty Ltd Method of supplementing nascent endogenous storage forms
EP1429782A4 (fr) * 2001-09-26 2005-02-02 Vital Health Sciences Pty Ltd Modulation du stockage de vitamines
JP4370451B2 (ja) 2001-09-28 2009-11-25 大塚製薬株式会社 医薬組成物
JP2003128531A (ja) 2001-10-17 2003-05-08 Nonogawa Shoji Kk 皮膚外用剤
CN1604772A (zh) * 2001-12-13 2005-04-06 生命健康科学有限公司 化合物的透皮转运
US20040116514A1 (en) 2002-01-31 2004-06-17 Hoyoku Nishino Compositions for preventing human cancer and method of preventing human cancer
WO2003068209A1 (fr) 2002-02-14 2003-08-21 Sonus Pharmaceuticals, Inc. Sels de metformine a acides lipophiles
US7074825B2 (en) 2002-03-07 2006-07-11 Huanbiao Mo Composition and method for treating cancer
AU2002950713A0 (en) * 2002-08-09 2002-09-12 Vital Health Sciences Pty Ltd Carrier
US20040067890A1 (en) * 2002-10-04 2004-04-08 Gupta Shyam K. Ascorbic acid salts of organic bases with enhanced bioavailability for synergictic anti-aging and skin protective cosmetic compositions
US6645514B1 (en) 2002-12-19 2003-11-11 Access Business Group International, Llc Increasing skin cell renewal with water-soluble Vitamin E
CA2513427C (fr) * 2003-01-17 2012-03-27 Vital Health Sciences Pty Ltd. Composes possedant des proprietes antiproliferatives
US7033998B2 (en) * 2003-04-11 2006-04-25 All Natural Fmg, Inc. Alcohol-free transdermal insulin composition and processes for manufacture and use thereof
AU2003901815A0 (en) * 2003-04-15 2003-05-01 Vital Health Sciences Pty Ltd Phosphate derivatives
AU2003901813A0 (en) * 2003-04-15 2003-05-01 Vital Health Sciences Pty Ltd Pharmaceutical derivatives
AU2003901812A0 (en) * 2003-04-15 2003-05-01 Vital Health Sciences Pty Ltd Phosphates of secondary alcohols
US7207669B2 (en) 2003-12-19 2007-04-24 Arizona Chemical Company Jet printing inks containing polymerized fatty acid-based polyamides
WO2005081825A2 (fr) 2004-02-23 2005-09-09 Euro-Celtique S.A. Dispositif de distribution transdermique d'opioides empechant une utilisation abusive et contenant des microspheres d'antagonistes d'opioides
JP4847437B2 (ja) 2004-03-03 2011-12-28 バイタル ヘルス サイエンシズ プロプライアタリー リミティド アルカロイド製剤
JP4758347B2 (ja) 2004-06-29 2011-08-24 独立行政法人科学技術振興機構 ヒアルロン酸を用いた小型肝細胞の選択的培養法および分離法
JP5198858B2 (ja) * 2004-08-03 2013-05-15 バイタル ヘルス サイエンシズ プロプライアタリー リミティド 腸内投与のための担体
US20060120979A1 (en) 2004-12-02 2006-06-08 Joel Rubin Skin care composition comprising hydroquinone and a substantially anhydrous base
US20090239827A1 (en) 2005-03-03 2009-09-24 Esra Ogru Compounds having lipid lowering properties
KR20070108382A (ko) 2005-03-03 2007-11-09 바이탈 헬스 사이언시즈 피티와이 리미티드 항암성 화합물
JP4270212B2 (ja) 2005-03-29 2009-05-27 セイコーエプソン株式会社 基板間隔調整装置、基板間隔調整方法、および液晶表示装置の製造方法
US20060228395A1 (en) 2005-04-11 2006-10-12 Robert Lamb Vitamin E phosphate/phosphatidylcholine liposomes to protect from or ameliorate cell damage
MX2007015949A (es) * 2005-06-17 2008-03-07 Vital Health Sciences Pty Ltd Un vehiculo que comprende uno o mas derivados de fosfato de di- y/o mono-(agentes de transferencia de electrones) o complejos de los mismos.
KR100764679B1 (ko) 2005-07-22 2007-10-09 익수제약 주식회사 파록세틴을 함유하는 경피투여용 패취제
US7446096B2 (en) 2005-12-19 2008-11-04 Industrial Technology Research Institute Glutathione based delivery system
EP1973547A1 (fr) * 2005-12-23 2008-10-01 Vital Health Sciences Pty Ltd. Composés ayant des propriétés modulatrices de la cytokine
WO2008034178A1 (fr) 2006-09-21 2008-03-27 Salvatore Iemma Composition dépilatoire topique
JP5201858B2 (ja) 2007-03-26 2013-06-05 花王株式会社 遊離脂肪酸が低減された油脂の製造方法
FR2921259B1 (fr) 2007-09-26 2015-02-13 Lvmh Rech Utilisation cosmetique du phosphate de tocopherol comme agent anti-vieillissement de la peau
EP2113242A1 (fr) 2008-05-02 2009-11-04 Pangaea Laboratories Limited Antioxydant destiné à une utilisation dans des préparations cosmétiques, médicamenteuses et pharmaceutiques
US20090297591A1 (en) 2008-05-30 2009-12-03 Orient Pharma Co., Ltd. Compositions And Methods For The Transdermal Delivery Of Pharmaceutical Compounds
JP5132700B2 (ja) 2010-02-22 2013-01-30 三菱電機株式会社 手乾燥装置

Also Published As

Publication number Publication date
RU2006131997A (ru) 2008-04-10
IL177781A0 (en) 2006-12-31
DK1720551T3 (da) 2011-05-16
KR20060130195A (ko) 2006-12-18
BRPI0508125A (pt) 2007-07-17
EP1720551B9 (fr) 2011-09-21
EP1720551A4 (fr) 2007-04-04
JP2007526256A (ja) 2007-09-13
DE602005025979D1 (de) 2011-03-03
RU2477136C2 (ru) 2013-03-10
WO2005084678A1 (fr) 2005-09-15
EP1720551B1 (fr) 2011-01-19
US20100209459A1 (en) 2010-08-19
ATE495730T1 (de) 2011-02-15
NZ549567A (en) 2009-10-30
AU2005202477B2 (en) 2005-12-15
CA2557354A1 (fr) 2005-09-15
KR101173159B1 (ko) 2012-08-16
JP4847437B2 (ja) 2011-12-28
CA2557354C (fr) 2013-05-07
US20060281716A1 (en) 2006-12-14
EP1720551A1 (fr) 2006-11-15
IL177781A (en) 2015-03-31
AU2005202477A1 (en) 2005-09-22
US8529947B2 (en) 2013-09-10

Similar Documents

Publication Publication Date Title
IL177781A0 (en) Alkaloid formulations
TW200407322A (en) Novel imidazopyridines as cyclin dependent kinase inhibitors
UA83091C2 (en) Pyrido[2,3-d]pyrimidine-2,4-diamines as pde 2 inhibitors
AU2003228770A1 (en) Substituted pyrazolopyrimidines
WO2006078287A3 (fr) Inhibiteurs de pde4b
AU2002246728A1 (en) Carboline derivatives
IL185611A0 (en) Novel imidazo[1,5-a]pyridine derivatives, method for preparing same and pharmaceutical compositions containing same
MX2010006212A (es) Compuestos organicos.
WO2002020489A3 (fr) Inhibiteurs quinoline de la cgmp phosphodiesterase
HK1071756A1 (en) Pyrazolopyrimidines suitable for the treatment of cancer diseases
TW200608977A (en) Substituted 2-alkyl quinazolinone derivatives as parp inhibitors
IL163781A0 (en) Purine derivatives as kinase inhibitors
TW200635591A (en) 1-(2-methylpropyl)-1H-imidazo[4,5-c][1,5]naphthyridin-4-amine ethanesulfonate and 1-(2-methylpropyl)-1H-imidazo[4,5-c][1,5]naphthyridin-4-amine methanesulfonate
AU2002249890A1 (en) Carboline derivatives
UA97629C2 (ru) Фармацевтическая композиция, имеющая противоопухолевую активность, и способы
MY136840A (en) Pyrazolopyridines as cyclin dependent kinase inhibitors
WO2004106339A3 (fr) Derives substitues en 4 de pyrazolo[3,4-d]pyrimidine et de pyrrolo[2,3-d]pyrimidine et leurs utilisations
TW200626600A (en) Octahydropyrrolo[3, 4-c]pyrrole derivatives
AU2003217712A1 (en) Pyrazolopyrimidine and pyrazolotriazine derivatives and pharmaceutical compositions containing them
WO2005028474A3 (fr) Inhibiteurs de chk-1
RS51912B (en) 1,2,3,4-TETRAHYDROPYROLO (1,2-a) PYRAZINE-6-CARBOXAMIDE AND 2,3,4,5-TETRAHYDROPYROLO (1,2-a) (1,4) -DIAZEPIN-7-CARBOXAMIDE DERIVATIVES THEIR OBTAINING AND THERAPEUTIC APPLICATION
TW200640932A (en) Clopidogrel base suitable for pharmaceutical formulation and preparation thereof
WO2001019826A3 (fr) Nouveaux composes
PL1814879T3 (pl) Pochodne 4,7-dioksobenzotiazolo-2-karboksyamidu, ich wytwarzanie oraz ich zastosowania terapeutyczne
PL371365A1 (en) Benzothiazole- and benzoxazole-4,7-dione derivatives and their use as cdc25 phosphatase inhibitors

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20170303